InvestorQ : How do you see the impact of Lupin getting approval for its diabetes drug?
sarah Leo made post

How do you see the impact of Lupin getting approval for its diabetes drug?

Answer
user profile image
1 month ago


On 04 August Lupin announced that it had received approval from the US FDA to market a generic diabetes drug in America. The tentative approval from the USFDA pertains to its Empagliflozin tablets, which will be available in strengths of 10 mg and 25 mg.

This drug that is likely to be launched by Lupin in the US markets is a generic version of Boehringer's Jardiance tablets, an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

As per latest sales data, the particular drug had annual sales of around $4.37 billion in the United States alone. Even as approvals have turned quicker for Indian pharma companies, this will be a boost for the company’s stock.